Most Popular

M & A Deals | M & A League Table | Real Assets | Sector Events |  Private Capital Conference

Australia: Michael Baker to succeed James Garner as CEO at Percheron Therapeutics

Life Sciences Nick Herbert -
ASX-listed Percheron Therapeutics, an international biotechnology company focused on developing novel therapies for oncology and rare diseases, has announced changes to the company’sexecutive leadership. Dr Michael Baker has been appointed to the role of managing director and CEO, effective 5 October. He succeeds Dr James Garner, CEO and managing director...

Switzerland: Hochdorf and Pharmalys form joint venture backed by AS Equity Partners

Consumer Healthcare Nick Herbert -
Hochdorf Swiss Nutrition, a leading Swiss producer of infant nutrition and functional milk powders, and Pharmalys Laboratories, a Swiss specialist in premium infant nutrition, have launched Hochdorf Laboratories, a strategic joint venture aimed at strengthening their position in the global infant nutrition market. Backed by AS Equity Partners, the new company brings together Hochdorf’s manufacturing expertise and Swiss production capabilities with Pharmalys’ established brands and international commercial reach. The JV integrates key assets - including infant nutrition brands, intellectual property and technical know‑how - into a single legal entity to...